INOVIO PHARMACEUTICALS INC (INO)

US45773H4092 - Common Stock

13.88  +0.85 (+6.52%)

After market: 13.99 +0.11 (+0.79%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to INO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 19.64. This target is 41.46% above the current price.
INO was analyzed by 8 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about INO.
In the previous month the buy percentage consensus was at a similar level.
INO was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 13.888.0814.7919.6442.00 - -41.79% 6.56% 41.46% 202.59%
Up and Down Grades
Date Firm Action Rating
2024-03-08 Oppenheimer Maintains Outperform -> Outperform
2024-03-07 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-01-25 Oppenheimer Upgrade Perform -> Outperform
2024-01-04 JMP Securities Initiate Market Outperform
2023-05-11 RBC Capital Reiterate Sector Perform -> Sector Perform
2023-03-02 RBC Capital Maintains Sector Perform
2022-11-09 Maxim Group Downgrade Buy -> Hold
2022-11-01 B of A Securities Downgrade Neutral -> Underperform
2022-08-10 RBC Capital Maintains Sector Perform
2022-05-11 Oppenheimer Downgrade Outperform -> Perform
2022-03-02 RBC Capital Maintains Sector Perform
2022-01-21 B of A Securities Upgrade Underperform -> Neutral
2021-11-01 RBC Capital Maintains Sector Perform
2021-09-10 B of A Securities Downgrade Neutral -> Underperform
2021-06-24 Jefferies Initiate Hold
2021-03-23 B of A Securities Initiate Neutral
2021-02-12 Oppenheimer Initiate Outperform